The Leadless AV Versus DDD Pacing Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Leadless AV Versus DDD Pacing Study — Stella

Home/Cardiac Pacemaker/

View on ClinicalTrials.gov

Recruiting

Back to Cardiac Pacemaker trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Switzerland

Inselspital, Bern University Hospital, Bern

Key details

Phase

Post-approval study

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

University of Bern

Enrollment target

~100 participants

Started

August 2022

Primary completion

December 2026

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

70 Years and older

Last updated March 2026